ABA Autism denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for aba autism are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Applies Step Therapy to ABA

Step therapy (sometimes called "fail first") for Applied Behavior Analysis (ABA) in autism spectrum disorder (ASD) typically requires that a patient try and fail a less-intensive or lower-cost behavioral intervention before the insurer will authorize ABA. For a behavioral health service like ABA, this can take the form of requiring documentation that school-based services, social skills groups, or parent-training-only approaches were attempted first. When that documentation is absent or the treating team did not know it was required, the authorization is denied and labeled a step-therapy failure.

## Why This Denial Is Often Overturned

Several arguments support appeal. First, the step-therapy requirement may constitute a Non-Quantitative Treatment Limitation under the Mental Health Parity and Addiction Equity Act (MHPAEA): if UHC does not impose analogous "fail first" requirements on comparable physical-health rehabilitative services, the ABA step requirement may be unlawfully more restrictive. Second, many states have enacted step-therapy reform laws that restrict when insurers may require fail-first protocols and provide a right to exemption when step therapy is clinically contraindicated. Third, school-based services are funded under IDEA (federal education law) and are not equivalent to clinical ABA — courts and regulators have consistently declined to treat educational services as clinical step-therapy substitutes.

## Federal Appeal Rights

ACA Section 2719 entitles you to free external review after internal appeals are exhausted (for fully-insured plans). ERISA Section 503 covers self-funded plans. The external-review window is approximately four months from final internal denial. Request the expedited track when developmental regression is at risk from delayed treatment.

## Documentation to Gather

• Treating clinician step-therapy exemption request: A letter from the prescribing physician or psychologist explaining why the required first-step treatment is clinically contraindicated, has already been tried and failed, or is otherwise inappropriate for this patient.
• History of prior interventions: Dates, providers, durations, and documented outcomes for any behavioral or developmental services already attempted.
• School services documentation: If school-based services are the required step, document their scope and explain why they do not meet clinical ABA standards for this patient's needs.
• ASD diagnosis and functional assessment: Current formal evaluation with codes and a recent standardized behavioral assessment.
• State step-therapy law: Research whether your state has enacted a step-therapy override law — if so, cite the statute directly in the appeal.

## Appeal Structure

1. Invoke the applicable state step-therapy exemption process if available. 2. Submit the clinical exemption letter documenting why step therapy is inappropriate. 3. Raise the MHPAEA parity argument: request the plan's NQTL analysis and identify any medical-benefit comparators without a fail-first requirement. 4. If internal appeals fail, file for external review immediately.